← Back to headlines
Gilead Sciences Acquires Ouro Medicines, Partners with Galapagos
Gilead Sciences has announced its acquisition of Ouro Medicines and a subsequent collaboration with Galapagos on the newly purchased assets, as reported by the Wall Street Journal.
23 Mar, 23:35 — 23 Mar, 23:35
Sources
Showing 1 of 1 sources



